Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Alterity Therapeutics Limited
ATHE | US
3.71
USD-0.13
-3.38%
ATHE | US
About Alterity Therapeutics Limited
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
10/04/2026
Close
3.71
Open
3.84
High
3.84
Low
3.53
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease Huntington disease Parkinson's disease and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne Australia.
View LessATHE | US
Risk
70.5
Sharpe
0.56
Luna's Score
61/100
Recommendation
Hold
Luna says (ATHE | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
High Short-term Volatility
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
78.0%1 month
70.5%3 months
58.3%6 months
62.4%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.14
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
0.75
Ent. to rev.
113.99
PEG
-
Other Fundamentals
EBITDA
-19.57M
MarketCap
32.48M
MarketCap(USD)
32.48M
Div. yield
-
Op. margin
-612.91
Erngs. growth
-
Rev. growth
38.40
Ret. on equity
-104.47
Short ratio
0.87
Short perc.
0.11
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.81
Range1M
0.81
Range3M
0.88
Volumes: Market Activity
Rel. volume
0.50
Price X volume
21.72K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.75 | - | Expensive |
| Ent. to Revenue | 113.99 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 1.14 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 58.30 | - | Par |
| Debt to Equity | 0.01 | -1.23 | Expensive |
| Debt to Assets | 0.01 | 0.25 | Cheaper |
| Market Cap | 32.48M | - | Emerging |
